Treatment Patterns and Outcomes in HER2-positive advanced breast cancer - a Cancer Centre cohort study in collaboration with Data-Can
Dr Mahéva Vallet
Cancer
New medicines are in development that may improve survival after treatment for breast cancer. The UK regulators and NHS Scotland need strong evidence on the value of new treatments prior to approving medicines as standard care paid for by the NHS.
While clinical trials can provide much of this evidence, there is also a need to provide evidence on the current ‘real-world’ patient population, standard treatments and current outcomes.
The project will generate real world evidence on the current metastatic breast cancer patient pathway, on patients from NHS Cancer Centres in Leeds, Lon...
Read More